Search Results

Rexulti (brexpiprazole) is a prescription drug approved to treat major depressive disorder and schizophrenia. Approved by the U.S. Food and Drug Administration in 2015, the medication is developed by Otsuka Pharmaceutical, the makers of the top-selling antipsychotic drug Abilify®. However, the two drugs may have more than just a manufacturer in common. Similar to Abilify, taking Rexulti may increase the likelihood of compulsive behaviors, such as pathological (more...)